George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

Exclusive: Life Sciences Investor Briefing - Destiny Pharma #DEST, Shield #STX & Open Orphan #ORPH


If you are curious about investing in Life Sciences but don't know much about it, our Life Sciences Investor Briefing may be for you. Or if you are already invested, this is an ideal opportunity to catch up with the sector.

London South East have partnered with Hardman & Co who have an expertise in the Life Sciences and Biotech fields, and we were joined on the evening of 11 September by the CEO of Destiny Pharma, the CFO of Shield Therapeutics and the CEO of Open Orphan, all AIM-listed companies. The evening was kicked off by Dr Martin Hall who heads the Hardman Life Sciences team and he puts the sector in context for us.

This webcast is an 'as-live' record of the event and includes the Q&A after each presentation.

Our speakers were:

1. Dr Martin Hall, Head of Life Sciences, Hardman & Co 6:51

2. Neil Clark, CEO, Destiny Pharma 36:32

3. Tim Watts, CFO, Shield Therapeutics 1:01:16

4. Cathal Friel, CEO, Open Orphan 01:29:42

Alba Mineral Resources Share Placing RNS Reaction

What's Hot Easter 2024

Sovereign Metals: Follow-Up Drilling

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.